Log in to save to my catalogue

Type 17-specific immune pathways are active in early spondyloarthritis

Type 17-specific immune pathways are active in early spondyloarthritis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1632d54ad26941bea5e5f23ce49f79fa

Type 17-specific immune pathways are active in early spondyloarthritis

About this item

Full title

Type 17-specific immune pathways are active in early spondyloarthritis

Publisher

England: EULAR

Journal title

Rheumatic & musculoskeletal diseases open, 2023-12, Vol.9 (4), p.e003328

Language

English

Formats

Publication information

Publisher

England: EULAR

More information

Scope and Contents

Contents

ObjectiveUndifferentiated, early inflammatory arthritis (EIA) can differentiate into seropositive or seronegative rheumatoid arthritis (RA), peripheral spondyloarthritis (SpA) or remain as seronegative undifferentiated inflammatory arthritis (UIA). Little is known about immune pathways active in the early stages of SpA and seronegative UIA, in cont...

Alternative Titles

Full title

Type 17-specific immune pathways are active in early spondyloarthritis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1632d54ad26941bea5e5f23ce49f79fa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1632d54ad26941bea5e5f23ce49f79fa

Other Identifiers

ISSN

2056-5933

E-ISSN

2056-5933

DOI

10.1136/rmdopen-2023-003328

How to access this item